Aimmune Nestlé Health Science US R&D
Clinical trials sponsored by Aimmune Nestlé Health Science US R&D, explained in plain language.
Aimmune is a biopharmaceutical company focused on developing treatments for food allergies, now part of Nestlé Health Science.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New enzyme could help digest food for those with pancreatic problems Results expected Jun 2027 (estimated)